nex-Zol Pharma
Developer of locally-enhanced topical transdermal formulations focused on improving skin penetration, tissue retention, and sustained (time-release) delivery. Publishes comparative permeation data and seeks development partners and investors to advance formulation development.
Industries
health-care
medical
pharmaceutical
nex-Zol Pharma
San Clemente, California, United States, North America
Products
Locally-enhanced topical transdermal formulation (prototype)
A topical formulation designed for enhanced skin penetration, increased tissue retention, and time-released delivery; sample data shows higher permeation and flux versus comparator formulations.
Locally-enhanced topical transdermal formulation (prototype)
A topical formulation designed for enhanced skin penetration, increased tissue retention, and time-released delivery; sample data shows higher permeation and flux versus comparator formulations.
Services
Investor and development partnerships
Facilitation of funding and collaborative development relationships with investors and external partners.
Investor and development partnerships
Facilitation of funding and collaborative development relationships with investors and external partners.
Expertise Areas
- Topical and transdermal formulation development
- Skin permeation and delivery evaluation
- Formulation performance benchmarking
- Sustained-release topical delivery
Key Technologies
- Locally-enhanced transdermal formulations
- In vitro skin permeation testing
- Flux/permeation rate analysis
- Sustained-release topical delivery methods